The organization faces the need to transition their analytics platform to cloud computing to improve speed and efficiency in disease detection and diagnostic processes. They also require advanced data visualization tools to enhance biological data exploration and discovery. Expanding product offerings and accurately identifying disease biomarkers are critical pain points that hinder rapid research and development.
A large biotech research organization specializing in genomics and proteomics data analysis to advance human disease detection and diagnostics, especially in cancer research.
The implementation of this cloud-based analysis and visualization platform aims to significantly accelerate disease biomarker discovery, improve algorithm analysis capabilities, and enable the identification of novel pathways and drug targets. This will facilitate faster development of diagnostics and therapeutics, leading to a measurable increase in research productivity and discovery efficiency.